Huapont Pharm has been focusing on retinoids since start-up of its business, and are proud of a lot of experts with rich developing and manufacturing experiences.
We manufacturing APIs including:
● First generation:
Tretinoin (Retinoic acid), Isotretinoin and Alitretinoin
● Second generation:
● Third generation:
Adapalene, Bexarotene and Tazarotene
We also manufacture Tretinoin cream, Isotretinoin soft capsules, Acitretin capsules, Adapalene cream and Tazarotene cream/gel.
A new finished product plant of Huapont Pharm will be put in use in 2018, covering an area about 113516 m2 and total construction area more than 180000 m2. The new plant is designed to comply with EU GMP with a total investment of 1 billion RMB.
With a 5-times capacity increment by comparing with the current plant, the new plant has 7 production lines which can manufacture：
● 25 million units for external preparations,
● 35 million units for external preparations (hormones),
● 2 billion units for tablets,
● 0.6 billion units for hard capsules,
● 7.2 million units for small volume injections,
● 50 million units for oral solution
● 25 million units for soft capsules.